Allows Medical marijuana?: Yes
Allows Adult-Use marijuana?: No
2018 Medical Sales : $219,000,000
2022 Projected Medical Sales : $504,000,000
2018 Adult Use Sales : N/A
2022 Projected Adult Use Sales : N/A
Noteworthy Information: New York has a restrictive dispensary system, along with limited doctor participation and product availability, though the state is working on trying to improve the system. Smoking is not permitted and the regulations prohibit edibles. Beginning on September 1,2 018, the New York Police Department will begin issuing tickets for people who smoke marijuana in public instead of arresting them. Opioid Use will soon be added as a qualifying medical condition.
Is there a Regulatory Structure? (State Agency): Yes (New York State Department of Health)
# of Dispensaries Allowed (# issued): Registered Organization Licenses (Each licenses includes a production facility and 4 dispensary locations)
(10 issued) [21 storefronts open]
# of Cultivations Allowed (# issued): N/A
# of Manufacturers Allowed (# issued): N/A
# of Testing labs Allowed (# issued): Until independent laboratories are certified in New York State to test medical marijuana products, the Department of Health's Wadsworth Laboratories is conducting the final product testing.
Geographic Distribution of Licenses: Geographically distributed
Registered Organization Application = $10,000
Registered Organization Renewal Application = $10,000
Registered Organization Registration Fee= $200,000 (submitted at time of application, and refunded if application is subsequently denied)
Registered Organization Registration Renewal Fee= $200,000 (submitted at time of application, and refunded if application is subsequently denied)
Patients and Caregivers must be residents, but the law is silent regarding owners of dispensaries, though residency must be disclosed.
Vertical Integration Allowed, Required or Prohibited:
Medical Marijuana Qualifying Patient Conditions:
Positive status for HIV or AIDS
Amyotrophic lateral sclerosis (ALS)
Damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity
Inflammatory bowel disease
Chronic pain as defined by 10 NYCRR §1004.2(a)(8)(xi)
Post-traumatic stress disorder or Huntington's disease.
Patients must also have one of the following associated or complicating conditions:
- Cachexia or wasting syndrome
- Severe or chronic pain
- Severe nausea
- Severe or persistent muscle spasms
Yes. All medical marijuana products produced by a Registered organization must be examined in a laboratory located in NY State that I licensed by the DEA and approved for analysis of medical marijuana by the Department.
New Leaf Cannabis Consulting can help you achieve cannabis licensure in New York
The team at New Leaf Cannabis Consulting has assisted cannabis businesses launch successfully throughout the United States. Team New Leaf are high level professionals who are also veterans of this industry: We know what it takes to take you step by step through the licensing process even when regulatory details are unclear.
To learn more or get started, contact us today. We look forward to helping your cannabis business take off in New York.
New Leaf Cannabis Business News
State By State Licensing Information
Legality of Cannabis in the United States
Leary v. United States (1969)
Ravin v. State (1975)
Conant v. McCaffrey (2000)
Gonzales v. Raich (2005)
Moncrieffe v. Holder (2013)